Safety update for influenza vaccines in Europe and Australia

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1321卷 / 1期
关键词：
Influenza; Influenza Vaccine; Narcolepsy; Western Australia; CHMP;
D O I：
10.2165/00128415-201013210-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [21] A review of the changes to the licensing of influenza vaccines in Europe
    Wijnans, Leonoor
    Voordouw, Bettie
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2016, 10 (01) : 2 - 8
  • [22] Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
    Uhart, Mathieu
    Bricout, Helene
    Clay, Emilie
    Largeron, Nathalie
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2259 - 2268
  • [23] Near real-time safety surveillance of three seasonal influenza vaccines in Europe during influenza season 2017/18
    Banga, Sonja
    Chabanon, Anne-Laure
    Eymin, Cecile
    Caroe, Tim
    Butler, Karina
    Moureau, Annick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 396 - 396
  • [24] Defining the safety profile of pandemic influenza vaccines
    Pfeifer, Dina
    Alfonso, Claudia
    Wood, David
    LANCET, 2010, 375 (9708): : 9 - 11
  • [25] Immunogenicity, safety and tolerability of intradermal influenza vaccines
    Hung, Ivan F. N.
    Yuen, Kwok-Yung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (03) : 565 - 570
  • [26] Safety and Efficacy of Inactivated Influenza Vaccines in Children
    Collignon, Peter
    Doshi, Peter
    Del Mar, Chris
    Jefferson, Tom
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (03) : 489 - 489
  • [27] Tools for monitoring the safety and effectiveness of influenza vaccines during an influenza pandemic
    McMahon, Ann
    Haber, Penina
    Belongia, Edward
    Pfeifer, Dina
    Caubel, Patrick
    Shay, David
    Davis, Robert
    Braun, Miles
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S76 - S76
  • [28] Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
    Vellozzi, Claudia
    Burwen, Dale R.
    Dobardzic, Azra
    Ball, Robert
    Walton, Kimp
    Haber, Penina
    VACCINE, 2009, 27 (15) : 2114 - 2120
  • [29] Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines
    Bekkat-Berkani, Rafik
    Ray, Riju
    Jain, Varsha K.
    Chandrasekaran, Vijayalakshmi
    Innis, Bruce L.
    EXPERT REVIEW OF VACCINES, 2016, 15 (02) : 201 - 214
  • [30] Vaccines Europe reflection paper on the safety assessment of residuals and contaminants in vaccines
    Damsten, Micaela
    Segal, Lawrence
    Gould, Sarah
    Finkelstein, Martin
    Frantz, Christopher
    Geuns, Ed
    Herzyk, Danuta
    Mulder, Mariska
    Novicki, Deborah
    Smith, Thomas
    TOXICOLOGY LETTERS, 2013, 221 : S211 - S211
12345